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Abstract A PCR-based subtractive cloning procedure was used
to identify genes expressed at higher levels in the pancreatic beta
cell line LTC1, as compared to the pancreatic alpha cell line
KTC1. One of the clones isolated by this procedure corresponded
to the regulatory subunit (RIK) of protein kinase A (PKA). Using
antibodies directed against RIK, we now demonstrate both by
immunoblot and immunofluorescence that RIK protein is present
at higher levels in cultured beta cells as compared to alpha cells.
In vitro PKA assays revealed high basal PKA activity in KTC1
extracts, which changed little on addition of exogenous cAMP.
On the other hand, extracts from beta cells showed very low
basal activity of PKA, which was elevated upon addition of
cAMP. A similar trend was observed in vivo using transfected
luciferase constructs bearing multiple copies of a CRE element:
in KTC1 cells, no induction by forskolin was observed, whereas in
LTC1 cells, forskolin produced a 9-fold increase in activity.
Therefore, the results indicate that RIK of PKA is selectively
expressed in pancreatic beta cells as compared to alpha cells : this
selective expression is associated with major differences in the
properties of the PKA signal transduction pathway. Differential
expression of the regulatory subunit may play a role in
determining the patterns of gene expression and signal transduc-
tion characteristic of alpha and beta cells.
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1. Introduction
The endocrine pancreas contains four distinct cell types,
alpha, beta, delta, and PP, which are specialized hormone-
secreting cells. Despite the similar morphology and common
embryological origins of these cells, they have quite distinct
biological functions [1]. The major function of the beta cell is
production and secretion of the key metabolic hormone insu-
lin [2], whereas alpha cells selectively express the gene encod-
ing the hormone glucagon [3]. In both cases, secretion is pre-
cisely regulated according to metabolic requirements: glucose
is a key regulator, exerting direct but inverse e¡ects on beta
and alpha cells. Elevated glucose concentrations lead to in-
creased insulin secretion through the activity of glucokinase, a
low a⁄nity isozyme of hexokinase, which is expressed in beta
cells [4]. High blood glucose levels generate an elevated ATP/
ADP ratio, which in turn leads to closure of K channels,
opening of Ca2 channels and increased secretion of insulin,
presumably through phosphorylation of as yet unidenti¢ed
target proteins [5]. In contrast, elevated glucose levels inhibit
glucagon secretion from alpha cells, through mechanisms
which may also involve glucokinase, which was recently iden-
ti¢ed in alpha cells [6].
Most likely, the di¡erences between alpha and beta cells
arise during the course of development, as a result of activa-
tion of characteristic sets of transcription factors, which in
turn lead to expression of alpha- and beta-speci¢c genes.
Thus far, only a small number of transcription factors ex-
pressed di¡erentially in alpha and beta cells have been iden-
ti¢ed [7^9]. In order to better understand the distinctive prop-
erties of alpha and beta cells, we undertook a subtractive
hybridization approach employing representational di¡erence
analysis (RDA), a procedure for cloning di¡erentially ex-
pressed genes [10]. We chose to compare the established cell
lines LTC1 and KTC1, because of the ready availability of
mRNA from these cells, and because of the similarity of the
procedures used to generate the lines (transgenic mice bearing
insulin/glucagon promoter linked to SV40 T antigen [11,12]),
which should reduce the number of false positive clones iso-
lated. One of the genes we isolated using this procedure en-
codes RIK, a regulatory subunit of protein kinase A (PKA),
thus con¢rming a recent report [13].
The PKA signal transduction pathway plays an important
role in mediating the e¡ects of a broad range of extracellular
signals [14]. Hormonally mediated increases in intracellular
cAMP levels lead to dissociation of the catalytically inactive
complex of PKA (R2C2) containing a cAMP-binding regula-
tory subunit (R) and free (catalytically active) subunit (C); the
active catalytic subunit then phosphorylates multiple target
proteins including the transcription factor CREB [15]. Four
distinct R isoforms (RIK, RIL, RIIK, RIIL) and two C iso-
forms (CK and CL) have been characterized in mouse [16].
The precise role of each of these is not clearly established.
There is some degree of functional overlap, since gene disrup-
tion of RIL or RIIL in mice is accompanied by a compensa-
tory increase in RIK protein [17]. On the other hand, RIK null
mutant mice show a phenotype of early embryonic death [17],
indicating a unique, non-redundant role for this isoform. Ac-
tivators of the PKA pathway e.g. forskolin and glucagon-like
peptide (GPI) can synergize with glucose in insulin secretion,
indicating an important functional link between insulin secre-
tion and the PKA pathway [18,19].
In this report, we demonstrate that the di¡erential expres-
sion of RI isoforms at the RNA level is re£ected also at the
protein level. Furthermore, using in vitro and in vivo assay,
we show that this di¡erential expression appears to have im-
portant functional consequences on the recruitment of the
PKA pathway.
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2. Materials and methods
2.1. Cell lines
KTC1-6 [20] (mouse glucagon-producing cells) and LTC1 [11]
(mouse insulin-producing cells) were grown in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 15% horse serum and
2.5% fetal calf serum and penicillin/streptomycin.
2.2. RNA preparation and cDNA-RDA protocol
Total RNA was prepared by using the TRI reagent kit (Molecular
Research Center, Inc.) followed by DNAse I treatment for 20 min at
37‡C. Poly(A) RNA was selected on an oligo dT cellulose column
(Boehringer Mannheim). For the cDNA synthesis, two cycles of
poly(A) selection were performed, and 10 Wg of RNA were used
to synthesize ds-cDNA [21]. Two Wg ds-cDNA were used for the
RDA procedure, and all steps were performed as described [10].
The DP3 was cut with DpnII, separated on 1.5% low melting point
agarose gel, excised from the gel with Jetsorb resin (Genomed) and
cloned into the BamHI site of pBS-KS vector, which was transformed
into E. coli DH5K or XL-1 blue.
2.3. Slot blot analysis
RNA was resuspended in a solution of 50% formamide, 7% form-
aldehyde, 1USSC (150 mM NaCl, 15 mM Na citrate) and incubated
at 68‡C for 15 min. The denatured sample was applied to a Nylon
membrane pre-washed with 20USSC, using a minifold II micro-sam-
ple ¢ltration manifold (Schleicher and Schuell), washed twice with
20USSC and UV cross-linked to the membrane. Probes were pre-
pared by random priming using a hexanucleotide mix (Boehringer
Mannheim), and ¢lters were hybridized overnight at 42‡C in a hybrid-
ization solution containing 50% formamide, 5UDenhardt’s solution,
5USSC, 0.1% SDS and 250 Wg/ml denatured salmon sperm DNA.
2.4. Immunoblot analysis
Cells were washed twice with PBS, trypsinized, resuspended in lysis
bu¡er (50 mM Tris pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM DTT,
1 mM PMSF, 10 Wg/ml leupeptin, 1 Wg/ml pepstatin and 50 Wg/ml
aprotinin) and sonicated. 100 Wg protein were separated on 12% SDS-
PAGE and transferred to nitrocellulose sheets. Membranes were
blocked with 10% (v/v) non-fat milk in 1UPBS and 0.05% Tween-
20 for 1 h, followed by incubation for 1 h with primary antibodies,
rabbit anti-RIK, or anti-catalytic subunit (antibody alpha P-2) [22]
diluted 1:1000 followed by protein A-horseradish peroxidase
(1:10 000) for 1 h, and visualization using the ECL (Amersham) re-
action.
2.5. Immunohistochemical staining
A mixture of LTC1 and KTC1 (1:1 ratio) was plated on a glass
cover slip and 48 h later cells were ¢xed with 4% paraformaldehyde
for 20 min, followed by permeabilization with 0.2% Triton X-100 for
5 min. Cover slips were incubated with appropriate concentrations of
primary antibodies (rabbit anti-RIK with guinea pig anti-insulin or
with guinea pig anti-glucagon) and secondary antibodies (£uores-
cein-conjugated donkey anti-rabbit and rhodamine-conjugated don-
key anti-guinea pig) were incubated for 1 h at room temperature.
Cells were examined using a Bio-Rad (model MRC1024) confocal
microscope.
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Fig. 1. RNA slot blot analysis: RNA was extracted from the cell
lines indicated at the top of the ¢gure and 10 Wg of total RNA was
applied to a nylon membrane. Membrane strips were hybridized
with the probes indicated on the left and exposed to a phosphoim-
ager screen.
Fig. 2. Immunoblot analysis: total protein was extracted from the
indicated cell lines and 100 Wg were fractionated on 12% SDS-
PAGE. Proteins were transferred to nitrocellulose membrane and in-
cubated with polyclonal antibodies directed against RIK (a), anti-
bodies directed against C or with non-immune sera (NIS) (b). The
expected sizes are: RI 48 kDa, and C 40 kDa. The non-speci¢c
band detected with NIS does not correspond to these sizes. The mi-
gration of molecular weight markers (kDa) is indicated.
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2.6. Kinase assay
To analyze kinase activity in the protein extracts, extract containing
10 Wg protein was incubated for 5 min at 30‡C in a reaction contain-
ing 50 mM HEPES pH 6.5, 10 mM MgAc, 1 mM EGTA, 100 WM
ATP, 10 WM Calmidazolium, 0.25 WCi Q32P-ATP and 50 Wg Histone
H2b in a ¢nal volume of 50 Wl. PKI (Calbiochem) was included,
where indicated, at a ¢nal concentration of 48 nM. Reactions were
spotted on P81 paper, washed 4 times for 15 min with 150 mM
phosphoric acid, then once with 70% ETOH and dried. Radioactivity
was measured in a liquid scintillation counter using Cerenkov radia-
tion.
2.7. Transfections
Cells were transfected with 10 Wg of a plasmid encoding a luciferase
reporter gene linked to a multimer of the CRE cis-element [23] and
5 Wg of the plasmid RSV-CAT as control for transfection e⁄ciency.
Glycerol shock (10%) was performed after 5 h, followed by addition
of forskolin (10 WM ¢nal concentration). Cells were harvested 40 h
later and luciferase (Promega luciferase reagent) or CAT assays were
performed using the phase extraction procedure [21].
3. Results
3.1. RIK subunit of PKA is selectively expressed in
pancreatic L cells
To compare the expression of the di¡erent subunits of PKA
at the RNA level, we performed RNA slot blot analysis with
RNA from six di¡erent mammalian cell lines: lymphoid cells
(L10), ¢broblasts (Ltk3), pancreatic L cells (LTC1) pancreatic
K cells (KTC1), muscle cells (C2), and pituitary endocrine cells
(GH3) (Fig. 1). RI mRNA levels (both RIK and RIL) were
highest in LTC1 cells compared to all other cell lines, whereas
comparable expression levels were seen for the catalytic sub-
units CK and CL in the di¡erent cell lines. In this experiment,
a probe for L actin (a gene expressed in most cell types) was
included as a qualitative indicator that comparable amounts
of RNA were loaded.
In order to examine expression at the protein level, immu-
noblot analysis was used. Sera raised against RIK, identi¢ed a
clear band (corresponding in molecular weight (48 kDa) to the
RI subunit) in extracts from LTC1 cells and RIN cells (an
independent beta cell line [24]). A much weaker band was
seen in Ltk3 ¢broblasts, whereas no band was seen for
KTC1 cells (Fig. 2a). On the other hand, use of antibodies
directed against the catalytic subunit indicated comparable
levels of this protein (Fig. 2b).
To con¢rm this preferential expression of RI subunit in
beta cells, we performed immuno£uorescence analysis using
co-cultured LTC1 and KTC1 cells. Double-labeling using
anti-insulin together with anti-RIK antibody (Fig. 3a^c)
showed that the insulin-producing LTC1 cells (Fig. 3a, red)
correspond with those cells containing high levels of RI (Fig.
3b, green); those cells not producing insulin (presumably
KTC1 cells) show much lower levels of RIK (Fig. 3b, green).
This is clearly seen in the merged photograph (Fig. 3c) and is
con¢rmed in the reciprocal experiment with anti-glucagon
antibodies, showing that the glucagon-producing cells
(KTC1) (Fig. 3d) show little or no detectable RI expression
(Fig. 3e).
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Fig. 3. Immuno£uorescent staining of KTC1 and LTC1 cells co-cultured on microscope cover slips. The top panels show a representative single
¢eld of cells double stained by incubation with guinea pig anti-insulin and rabbit anti-RIK antibodies followed by rhodamine anti-guinea pig
and £uorescein anti-rabbit antibodies and visualization of rhodamine (panel a) £uorescein (panel b) and the combined signals (panel c). The
bottom panels show a representative single ¢eld of cells double stained by incubation with guinea pig anti-glucagon and rabbit anti-RIK anti-
bodies followed by rhodamine anti-guinea pig and £uorescein anti-rabbit antibodies and visualization or rhodamine (panel d) £uorescein (panel
e) and the combined signals (panel f).
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3.2. Functional properties of PKA di¡er between L cells
and K cells
To examine the functional consequences of the selective
expression of the regulatory subunit we performed kinase as-
says with protein extracts from both KTC1 and LTC1 cells, in
the presence of increasing cAMP concentrations. With KTC1
extracts, high levels of protein kinase activity were seen in the
absence of cAMP. This activity is attributable to PKA, since
addition of its speci¢c inhibitor, PKI, eliminated essentially all
of it (Fig. 4). It should be noted however that addition of
increasing concentrations of cAMP, up to 1035 M, did not
enhance signi¢cantly the kinase activity. The complete inacti-
vation of activity by PKI, together with the lack of activation
upon addition of cAMP, suggest that in these cells PKA exists
in a persistently activated form. In contrast, in LTC1 cells, low
levels of activity were detected in the absence of cAMP, in-
creasing 7-fold upon addition of cAMP (Fig. 4). In this case
also, PKI was able to e⁄ciently inhibit this activity. This is
consistent with the idea that in the absence of cAMP, the
catalytic subunit in LTC1 extracts is mainly inactive, presum-
ably as a result of interaction with regulatory subunit. Upon
addition of cAMP, the catalytic subunit becomes activated
through dissociation of its R2C2 complex.
The in vivo function of the PKA signal transduction path-
way was examined by transfection of cultured cells with plas-
mids containing a luciferase reporter gene linked to a multi-
mer of the cAMP response element (CRE). Using LTC1 cells,
a very low basal level of reporter gene activity was observed;
incubation in the presence of forskolin, an adenylate cyclase
activator, produced a 9-fold activation (Fig. 5). By contrast,
with K cells basal levels were high: addition of forskolin had
little or no e¡ect on CRE-dependent transcription (Fig. 5).
These results closely parallel the data obtained from in vitro
PKA assays. Thus LTC1 cells have a low basal level of activ-
ity of PKA, which can be substantially elevated by cAMP.
KTC1 cells on the other hand, have a higher basal level, which
is not signi¢cantly a¡ected by cAMP.
4. Discussion
Despite similarities in morphology and embryological ori-
gins, pancreatic alpha and beta cells have very di¡erent phys-
iological roles: glucagon secretion from alpha cells serves to
mobilize glucose from the liver and thus elevates blood glu-
cose levels. On the other hand, insulin secretion from beta
cells increases glucose uptake by peripheral tissues, thereby
decreasing blood glucose levels. In order to accomplish its
specialized role of regulated secretion of a unique hormone,
each cell expresses a characteristic set of speci¢c genes; pres-
ently, relatively few such alpha and beta cell-speci¢c genes are
known [13,25]. The current work was undertaken with a view
to better understanding the function of alpha and beta cells
through cloning of genes expressed di¡erentially between
these two cell types. One of the genes thus identi¢ed was
RIK, a regulatory subunit of PKA.
In this report, we demonstrate that the di¡erential levels of
mRNA for RIK lead to substantial di¡erences also at the level
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Fig. 4. Kinase activity in KTC1 and LTC1 cells. Phosphorylation re-
actions were performed as described in Section 2 in the absence or
presence of increasing concentrations of cAMP. a: Kinase activity
from a representative experiment. b: Fold activation by cAMP (rel-
ative to level in the absence of cAMP). Results are the average of
three independent experiments þ S.E.M. PKI was added where indi-
cated.
Fig. 5. E¡ect of forskolin on CRE-dependent luciferase activity in
vivo. A reporter plasmid containing 16 copies of the CRE upstream
of the luciferase reporter gene, was transfected to KTC1 and LTC1
cells together with the plasmid RSV CAT as internal control. Fol-
lowing transfection, cells were incubated for 40 h in the presence of
forskolin. a: Normalized luciferase activity for a representative ex-
periment. b: Fold activation over non-treated cells. Results are the
average of three independent experiments þ S.E.M.
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of protein. This is of importance since previous studies have
revealed instances of post-transcriptional regulation of R sub-
unit gene expression; for example, disruption of the RIL or
RIIL genes in mice leads to biochemical compensation by RIK
without accompanying changes in RIK mRNA levels [17].
Low levels of RIK protein, as observed in KTC1 cells might
be expected to lead to presence of free catalytic subunit and
therefore high basal activity of PKA, fully sensitive to PKI
inhibition; on the other hand, high levels of RIK protein, as
observed in LTC1 cells might be expected to produce low
basal, but highly inducible catalytic activity of PKA, again
fully sensitive to PKI inhibition. In fact, this is exactly what
we have observed upon analysis through both in vivo and in
vitro experiments. These results suggest that the RI regulatory
subunit plays a dominant role in determining PKA properties
in these cells. Consistent with this, we have observed in pre-
liminary immunoblot experiments that levels of RII, unlike
RI, are similar in KTC1 and LTC1 cells (data not shown).
What might be the possible physiological implications of
di¡erential expression of RI? An interesting indication comes
from studies of gene extinction in hybrid cells. Somatic cell
hybrids formed between liver cells and ¢broblasts display
complete inhibition (extinction) of the liver phenotype [26].
It has been shown that this e¡ect is due to expression of a
small number of ‘extinguisher’ loci contributed by the ¢bro-
blast parent cell. One of these loci was cloned and shown to
correspond to the RIK gene; when the gene was transfected to
liver cells it substantially reduced the level of expression of a
number of liver-speci¢c genes [27,28]. Thus the intracellular
concentration of RIK subunit can play a crucial role in con-
trolling the expression of sets of tissue-speci¢c genes, even in
the absence of activators of the PKA pathway.
Di¡erential expression of RI might of course be expected to
a¡ect cellular responses to hormones and other extracellular
signaling molecules. The pancreatic beta cell is responsible for
regulating blood glucose levels in response to metabolic re-
quirements. Defects in this ability can lead to diabetes [2]. The
precise mechanism whereby regulation is achieved is complex
and remains poorly understood. The possible connection of
the PKA pathway in this process has been examined.
Although elevated cAMP levels are insu⁄cient to trigger in-
sulin secretion, cAMP can potentiate glucose-mediated insulin
release, presumably a re£ection of the biological function of
hormones such as glucagon and glucagon-like peptide 1 [18].
The di¡erential expression of RI is likely to have general
e¡ects on cell-speci¢c gene expression and on the response of
the PKA pathway to extracellular stimuli. Future studies will
focus on the downstream targets of PKA, including the po-
tential e¡ects of CREB on key endocrine genes, with a view to
understanding how key di¡erences in gene expression patterns
and signal transduction events are mediated.
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